Fufeng Group Ltd
HKEX:546
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/IC
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.
Valuation Scenarios
If EV/IC returns to its 3-Year Average (0.2), the stock would be worth HK$9.89 (52% upside from current price).
| Scenario | EV/IC Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 0.1 | HK$6.51 |
0%
|
| 3-Year Average | 0.2 | HK$9.89 |
+52%
|
| 5-Year Average | 0.2 | HK$13.06 |
+101%
|
| Industry Average | 1.9 | HK$104.56 |
+1 506%
|
| Country Average | 1.9 | HK$103.78 |
+1 494%
|
Forward EV/IC
Today’s price vs future invested capital
Peer Comparison
| Market Cap | EV/IC | P/E | ||||
|---|---|---|---|---|---|---|
| CN |
|
Fufeng Group Ltd
HKEX:546
|
16.3B HKD | 0.1 | 5.8 | |
| ZA |
S
|
Sasol Ltd
JSE:SOL
|
147B ZAR | 0.8 | 61 | |
| DE |
|
Basf Se
XETRA:BAS
|
48.4B EUR | 0.9 | 29.9 | |
| CN |
|
Ningxia Baofeng Energy Group Co Ltd
SSE:600989
|
225.1B CNY | 2.9 | 17.9 | |
| JP |
R
|
Resonac Holdings Corp
XMUN:SWD
|
13.8B EUR | 1.9 | 87.1 | |
| JP |
|
Showa Denko KK
TSE:4004
|
2.5T JPY | 1.9 | 87.6 | |
| ZA |
O
|
Omnia Holdings Ltd
JSE:OMN
|
15.1B ZAR | 1.3 | 12.7 | |
| IN |
|
Pidilite Industries Ltd
NSE:PIDILITIND
|
1.4T INR | 14.7 | 60.6 | |
| IN |
|
SRF Ltd
NSE:SRF
|
746.6B INR | 4 | 41.7 | |
| JP |
M
|
Mitsubishi Chemical Group Corp
F:M3C0
|
6.7B EUR | 0.4 | 13.4 | |
| JP |
|
Mitsubishi Chemical Holdings Corp
TSE:4188
|
1.2T JPY | 0.4 | 13.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.1 |
| Median | 1.9 |
| 70th Percentile | 3.4 |
| Max | 1 129 391.6 |
Other Multiples
Fufeng Group Ltd
Glance View
Fufeng Group Ltd., a company deeply rooted in the biochemical industry, operates at the intersection of modern agribusiness and advanced biotechnology. Founded in 1999 and headquartered in China, Fufeng has carved a niche for itself primarily as a producer of corn-based biochemical products. The company's operations revolve around transforming corn into a wide array of products such as monosodium glutamate (MSG), xanthan gum, and various amino acids. By leveraging fermentation techniques, they turn this abundant grain into essential ingredients used in food additives, animal nutrition, and other industrial applications. Their manufacturing prowess, combined with strategic research and development initiatives, enables them to deliver products that cater to a broad spectrum of industries worldwide. The economic engine driving Fufeng is its ability to scale production while maintaining control over supply costs, particularly the raw material—corn. With extensive manufacturing facilities spread across different regions of China, they enjoy the benefits of proximity to key agricultural hubs, ensuring they have a steady stream of raw inputs. This operational strategy helps them keep production costs competitive while exploring innovative product developments to meet evolving market demands. Furthermore, their commitment to sustainability and efficient resource utilization has fortified their market position, enabling them to adapt to various global economic climates and regulatory landscapes. As a result, Fufeng Group Ltd. continues to play a pivotal role in the global biochemical sector, converting agricultural resources into value-added products that touch everyday lives.